LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

86.59 -1.3

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

85.86

Макс.

88.29

Ключевые показатели

By Trading Economics

Доход

22M

141M

Продажи

57M

826M

P/E

Средняя по отрасли

30.356

66.845

Прибыль на акцию

1.28

Рентабельность продаж

17.013

Сотрудники

6,000

EBITDA

29M

244M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+24.62% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

54M

13B

Предыдущая цена открытия

87.89

Предыдущая цена закрытия

86.59

Новостные настроения

By Acuity

72%

28%

312 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 мар. 2026 г., 20:38 UTC

Отчет

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 мар. 2026 г., 23:57 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

10 мар. 2026 г., 23:57 UTC

Обсуждения рынка

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 мар. 2026 г., 23:47 UTC

Обсуждения рынка

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 мар. 2026 г., 23:35 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 мар. 2026 г., 23:06 UTC

Отчет

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 мар. 2026 г., 22:51 UTC

Главные новостные события

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 мар. 2026 г., 21:39 UTC

Приобретения, слияния, поглощения

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 мар. 2026 г., 21:21 UTC

Отчет

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 мар. 2026 г., 21:15 UTC

Отчет

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 мар. 2026 г., 21:15 UTC

Приобретения, слияния, поглощения

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 мар. 2026 г., 21:14 UTC

Отчет

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 мар. 2026 г., 21:13 UTC

Отчет

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 мар. 2026 г., 21:12 UTC

Отчет

Franco-Nevada 4Q Rev $597.3M >FNV

10 мар. 2026 г., 21:12 UTC

Отчет

Franco-Nevada 4Q EPS $1.90

10 мар. 2026 г., 20:57 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:50 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

10 мар. 2026 г., 20:44 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:34 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

10 мар. 2026 г., 20:34 UTC

Обсуждения рынка
Отчет

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 мар. 2026 г., 20:23 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:16 UTC

Отчет

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 мар. 2026 г., 20:14 UTC

Отчет

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 мар. 2026 г., 20:14 UTC

Отчет

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 мар. 2026 г., 20:13 UTC

Отчет

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 мар. 2026 г., 20:12 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

24.62% рост

Прогноз на 12 месяцев

Средняя 108.54 USD  24.62%

Максимум 123 USD

Минимум 87 USD

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

14 ratings

11

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

312 / 351Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat